Feed Preview

Killing Mechanisms

Killing Mechanisms diagram by VectorMine, Shutterstock
VectorMine, Shutterstock

Cytolytic t lymphocytes exert two main specific molecular killing mechanisms against target cells, namely (i) they can synthesize and release soluble cytolytic factors, and (ii) they can express effector molecules that act as ligands of receptors expressed by target cells on the cell surface. Here is the latest research on killing mechanisms.

Top 20 most recent papers
Clinical Lung Cancer

Design and Rationale for a Phase III, Randomized, Placebo-controlled Trial of Durvalumab With or Without Tremelimumab After Concurrent Chemoradiotherapy for Patients With Limited-stage Small-cell Lung Cancer: The ADRIATIC Study

Clinical Lung CancerJanuary 18, 2020
Suresh SenanByoung Chul Cho
Immunity

Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials

ImmunityJanuary 16, 2020
Jackson G EgenLawren C Wu
8
Immunity

Keeping T-he Killers at Bay via FcγRIIb

ImmunityJanuary 18, 2020
Falk Nimmerjahn
Immunity

Dimers Aren't Forever: CD80 Breaks up with PD-L1

ImmunityJanuary 18, 2020
David M Sansom, Lucy S K Walker
15
Leukemia

Correction: BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications

LeukemiaJanuary 18, 2020
Jooeun BaeKenneth C Anderson
1
bioRxiv

Multiplexed Single-cell Metabolic Profiles Organize the Spectrum of Human Cytotoxic T Cells

bioRxivJanuary 17, 2020
Felix J HartmannSean C Bendall
72
CA: a Cancer Journal for Clinicians

A review of cancer immunotherapy toxicity

CA: a Cancer Journal for CliniciansJanuary 17, 2020
Lucy Boyce Kennedy, April K S Salama
35
Cancer Research

Linking transcriptomic and imaging data defines features of a favorable tumor immune microenvironment and identifies a combination biomarker for primary melanoma

Cancer ResearchJanuary 18, 2020
Robyn D Gartrell-CorradoYvonne M Saenger
5
Methods in Enzymology

Assessment of IFNγ responsiveness in patient-derived xenografts

Methods in EnzymologyJanuary 18, 2020
Jordan J CardenasKaterina Politi
Science Translational Medicine

Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade

Science Translational MedicineJanuary 17, 2020
Shinsuke NakaoTakafumi Nakamura
31
1
Methods in Enzymology

Assessment of IFN-γ and granzyme-B production by in "sitro" technology

Methods in EnzymologyJanuary 18, 2020
Claudia GalassiIlio Vitale
Science Immunology

Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome

Science ImmunologyJanuary 19, 2020
Yuying LiuBo Huang
78
5
Journal of Clinical Immunology

Disseminated Pneumocystis jirovecii Infection with Osteomyelitis in a Patient with CTLA-4 Haploinsufficiency

Journal of Clinical ImmunologyJanuary 20, 2020
Aminaa E SiddiqiYael Gernez
Journal of Clinical Medicine

Anti-PD-1 and Novel Combinations in the Treatment of Melanoma-An Update

Journal of Clinical MedicineJanuary 18, 2020
Frank Friedrich GellrichFriedegund Meier
1
International Journal of Cancer. Journal International Du Cancer

Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: beyond an era of chemoradiation?

International Journal of Cancer. Journal International Du CancerJanuary 18, 2020
Liam MastersonMatt Lechner
bioRxiv

Human MAIT cell cytolytic effector proteins synergize to overcome carbapenem resistance in Escherichia coli

bioRxivJanuary 16, 2020
Caroline BoulouisEdwin Leeansyah
14
Pharmaceuticals

Mitogen-Activated Protein Kinase Inhibitors and T-Cell-Dependent Immunotherapy in Cancer

PharmaceuticalsJanuary 16, 2020
Sandeep KumarAjay Rana
1
Methods in Enzymology

A flow cytometry-based method to screen for modulators of tumor-specific T cell cytotoxicity

Methods in EnzymologyJanuary 18, 2020
Javier SantosSantos Mañes
Cancers

Photochemical Internalization: Light Paves Way for New Cancer Chemotherapies and Vaccines

CancersJanuary 16, 2020
Lara ŠošićPål Johansen
7
European Journal of Immunology

CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity

European Journal of ImmunologyJanuary 17, 2020
Faizah AlotaibiJames Koropatnick
3

See more papers from this feed

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Basophils

Basophils are myeloid cells with a high affinity IgE receptor and is involved in inflammatory responses during allergy. Discover the latest research on Basophils here.

Classical Complement Pathway

The Classical Complement Pathway is activated by antigen-antibody complexes. Activation of this pathway leads to the generation of the membrane attack complex, which kills pathogenic cells. Discover the latest research on the Classical Complement Pathway here.

Complement Pathway: Mannose-Binding Lectin

The Mannose-Binding Lectin Complement Pathway is activated when mannose-binding lectin binds to mannose found on the surface of pathogens. Subsequent complement activation is similar to the classical complement pathway, but without the need for antigen-antibody complexes. Discover the latest research here.

Inflammation Mediators

Inflammation Mediators include cytokines, prostaglandins and other molecules that ochestrate the inflammatory process in response to injury, allergy or pathogens. Discover the latest research on Inflammation Mediators here.

Innate Immunity and CNS

Innate immune responses in the CNS are carried out by microglia and astrocytes. Here is the latest research on mechanisms underlying innate immunity in the CNS and its impact on neurophysiology.

Innate Immunity in Lower Organisms

Many components of the mammalian innate immune system have homologs in lower organisms, such as invertebrates. Discover the latest research on Innate Immunity in Lower Organisms here.

Innate Immunity: Neurodegeneration

The innate immune system is a first line of defense against infection. Pathological states can occur if there is over activation of the innate immune system, particularly in the. The excessive activation of these cells can lead to inflammation and neurodegenerative diseases. Here is the latest research on innate immunity and neurodegeneration.

Intracellular Killing

Intracellular killing involves the death of microbes within the phagocyte. Here is the latest research on intracellular killing.

© 2020 Meta ULC. All rights reserved
/feed-previews/killing-mechanisms/65d0029f-a741-4129-af0b-b32bc9282798